Quick Answer
Imunon, Inc. reported Research And Development Expense of $7.78 million for the year ending 2025.
- Imunon, Inc. showed a decrease of -33.2% in Research And Development Expense from 2024 to 2025.
- This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $3.44 million | Q3 2010: $3.95 million | Q1 2011: $4.35 million | Q2 2011: $4.96 million | Q3 2011: $5.41 million | Q1 2012: $4.69 million | Q2 2012: $4.11 million | Q3 2012: $3.54 million | Q1 2013: $3.20 million | Q2 2013: $2.02 million | Q3 2013: $2.27 million | Q1 2014: $2.89 million | Q2 2014: $3.17 million | Q3 2014: $4.63 million | Q1 2015: $4.51 million | Q2 2015: $3.57 million | Q3 2015: $2.88 million | Q1 2016: $3.44 million | Q2 2016: $3.34 million | Q3 2016: $4.23 million | Q1 2017: $3.48 million | Q2 2017: $3.35 million | Q3 2017: $3.35 million | Q1 2018: $2.74 million | Q2 2018: $4.59 million | Q3 2018: $2.19 million | Q1 2019: $2.77 million | Q2 2019: $3.56 million | Q3 2019: $3.67 million | Q1 2020: $3.05 million | Q2 2020: $2.99 million | Q3 2020: $2.49 million | Q1 2021: $2.57 million | Q2 2021: $2.59 million | Q3 2021: $2.47 million | Q1 2022: $3.10 million | Q2 2022: $3.23 million | Q3 2022: $2.41 million | Q1 2023: $2.62 million | Q2 2023: $3.13 million | Q3 2023: $1.98 million | Q1 2024: $3.29 million | Q2 2024: $2.82 million | Q3 2024: $3.29 million | Q1 2025: $2.17 million | Q2 2025: $1.23 million | Q3 2025: $1.90 million.
- Over the full 16 years of available data (2010 to 2025), Imunon, Inc.'s Research And Development Expense has declined by 47.1%.
- Historical annual values: Fiscal year 2025: $7.78 million | Fiscal year 2024: $11.64 million | Fiscal year 2023: $11.29 million | Fiscal year 2022: $11.73 million | Fiscal year 2021: $10.62 million | Fiscal year 2020: $11.34 million | Fiscal year 2019: $13.07 million | Fiscal year 2018: $11.87 million | Fiscal year 2017: $13.08 million | Fiscal year 2016: $14.62 million | Fiscal year 2015: $14.66 million | Fiscal year 2014: $14.97 million | Fiscal year 2013: $9.36 million | Fiscal year 2012: $15.77 million | Fiscal year 2011: $19.86 million | Fiscal year 2010: $14.71 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: